Leveraging epitranscriptomics for cardiovascular disease theranostics

Eur Heart J. 2024 Apr 1;45(13):1098-1100. doi: 10.1093/eurheartj/ehad852.
No abstract available

MeSH terms

  • Cardiovascular Diseases* / genetics
  • Cardiovascular Diseases* / therapy
  • Humans
  • Precision Medicine*